1. Aravindh SA et al. MRI versus clinical assessment in staging and response evaluation in locally advanced cervix cancer patients treated with concurrent chemoradiation in a tertiary cancer center: a prospective study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2017 Feb;6(2):392-399.

2. Bin Liu. A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A MetaAnalysis Based on 67 Studies. Gynecol Obstet Invest 2017;82:209-222

3. Bing Liu, Wan-Ling Ma Changes in magnetic resonance T2-weighted imaging signal intensity correlate with concurrent chemoradiotherapy response in cervical cancer. J Contemp Brachytherapy. 2019 Feb; 11(1): 41–47.

4. Evelyn Dappa. [et al.]. The value of advanced MRI techniques in the assessment of cervical cancer: a review/ Evelyn Dappa [et al.] // Insights Imaging. – 2017. – Vol. 8(5). – P. 471-481.

5. Evis Sala, Andrea G. Rockall, Susan J. Freeman, Donald G. Mitchell, Caroline Reinhold, The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know Radiology 2013. 3:717-740.

6. Garima Agrawal Part 2: MR of the female pelvis./ Applied radiology.;The journal of practical medical imaging and management/ 2012 05. p. 141-8.

7. Helena Barbara Zobec Logar, Barbara Segedin, Robert Hudej, and Primoz Petric. Definitive radiotherapy for uterine cervix cancer: long term results for patients treated in the period from 1998 till 2002 at the Institute of Oncology Ljubljana. Radiol Oncol. 2013 Sep; 47(3): 280–288.

8. Jinhyun Choi, Hong In Yoon,The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994; 29:9-16.

9. Kodaira T, Fuwa N, Toita T. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56:769-77.

10.Park W. [et al.]. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer // Jpn. J. Clin. Oncol. – 2005. – Vol. 35, № 5. – P. 260-4.

11. Pecorelli S.: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet. 105 (2), 103-104 (2009).

12.Shelly Srivastava, Surendra Kumar Saini, Awadhesh Kumar Dixit, Deepti Dwivedi Prognostic significance of tumor volume as determined on 3D ultrasound scan in uterine cervix cancer treated by radiotherapy Journal of cancer research and therapeutics 2017.13.2. Page 324-328.

13.Аксель Е.М., Виноградова Н.Н. СТАТИСТИКА ЗЛОКАЧЕСТВЕННЫХ НОВООБРАЗОВАНИЙ ЖЕНСКИХ РЕПРОДУКТИВНЫХ ОРГАНОВ // Онкогинекология № 3’2018. С. 64-78

14.Чуруксаева О.Н., Коломиец Л.А. Прогностическое значение Ki 67, циклооксигеназы-2 (COX-2) и P16INK4A у больных местно-распространенным раком шейки матки // Сибирский онкологический журнал. 2016. № 5. С. 25–32.

15.Залуцкий И.В., Косенко И.А., Хильченко Е.И. и др. Рак шейки матки: анализ контингентов больных, стоящих на учёте в регионах Республики Беларусь с 1996 по 2005 год // Вопр. организ. и информатиз. здраво-охр. — 2007. — №3. — С. 3-8.

16.Океанов А.Е, Моисеев П.И., Левин Л.Ф. Статистика онкологических заболеваний / Под ред. 0. Г.Суконко. Белорусский канцер-регистр. — Минск, 2012. — С. 99-105.